Atropos Health’s Clinical Advisory Board

For years, the clinical data captured in healthcare settings has largely remained locked in the EHR system, beyond its use for billing purposes. Stakeholders across the healthcare ecosystem have long aspired to securely leverage this information for clinical purposes too. Namely - to learn from the data available to personalize care plans for patients, optimize care protocols, conduct population health studies, and more. Technical difficulties, limited provider bandwidth, time and resource limitations, and other factors have precluded the promise of evidence-based practice from becoming a reality at scale.

Atropos Health seeks to change this with a platform that generates novel retrospective observational studies in response to clinical questions. The process takes only 2 days and yields publication-grade real-world evidence. (See a Prognostogram report).

Now, this Clinical Advisory Board of healthcare leaders joins Atropos to expand access to its innovative technology. This will yield widespread benefit for healthcare institutions and enable personalized medicine for more patients.

A better group could not have formed to help Atropos close the evidence gap in medicine. Where patients are underrepresented in RCTs, together we will enable rapid production of credible observational evidence to inform care. Where QI initiatives are stymied by resource limitations, we will surmount those hurdles with clinically-informed analytics augmentation via Atropos Evidence Platform. The deep industry expertise these healthcare leaders offer will augment the commercialization of Atropos’ cloud-based, secure healthcare technology solutions and further its track record of  clinical & fiscal ROI .